2026 Q2 Portfolio Activity
In 2026 Q2, ADAR1 Capital Management, LLC maintained a portfolio of 355 distinct positions. The most significant new addition was EDITAS MEDICINE INC, now representing 1.32% of the total fund value. They heavily accumulated shares in ABIVAX SA, increasing the position by 4001.6%. The fund also reduced its exposure to ABIVAX SA by 96.8%.
Position History
hover any row below to update
Loading…
Total Positions
355
Quarter
2026 Q2
Top Holding
ABVX (11.0%)
Top 10 Concentration
40.8%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 355
ADAR1 Capital Management, LLC Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ABVX
ABIVAX SA
|
Healthcare | 11.01% | 9.14% |
#1
Prev: #1
|
8.5 |
—
|
410,684 | 29.5% |
P
S
|
1,804,703 | $240,494,722 |
$66.19
+73.7%
|
2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
PTGX
PROTAGONIST THE...
|
Healthcare | 5.39% | 6.17% |
#2
Prev: #2
|
4.2 |
—
|
-33,256 | -3.3% |
P
S
|
960,863 | $117,782,587 |
$35.59
+323.4%
|
2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
ROIV
ROIVANT SCIENCE...
|
Healthcare | 5.11% | 5.36% |
#3
Prev: #3
|
3.5 |
—
|
-128,898 | -3.9% |
P
S
|
3,157,008 | $111,726,513 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SPY
STATE STR SPDR ...
|
ETF | 4.41% | 2.91% |
#4
1
Prev: #5
|
5.3 |
—
|
53,147 | 70.0% |
P
S
|
129,087 | $96,398,299 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IMVT
IMMUNOVANT INC
|
Healthcare | 4.11% | 3.92% |
#5
1
Prev: #4
|
2.6 |
—
|
-348,294 | -13.0% |
P
S
|
2,330,716 | $89,802,487 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ZLAB
ZAI LAB LTD
|
Healthcare | 2.93% | 1.58% |
#6
6
Prev: #12
|
4.2 |
—
|
1,943,667 | 136.4% |
P
S
|
3,369,034 | $64,011,646 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AGIO
AGIOS PHARMACEU...
|
Healthcare | 2.19% | 0.28% |
#7
73
Prev: #80
|
3.9 |
—
|
1,147,381 | 815.6% |
P
S
|
1,288,053 | $47,799,647 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CRNX
CRINETICS PHARM...
|
Healthcare | 2.09% | 2.44% |
#8
Prev: #8
|
2.8 |
—
|
82,749 | 7.3% |
P
S
|
1,222,080 | $45,730,234 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BOXX
EA SERIES TRUST
|
Unknown | 1.81% | 2.31% |
#9
Prev: #9
|
1.7 |
—
|
no change | no change |
P
S
|
337,125 | $39,473,966 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 1.79% | 2.45% |
#10
3
Prev: #7
|
0.7 |
—
|
-174,649 | -27.6% |
P
S
|
457,907 | $39,009,097 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SEPN
SEPTERNA INC
|
Healthcare | 1.44% | 1.54% |
#11
2
Prev: #13
|
1.1 |
—
|
-149,071 | -13.7% |
P
S
|
940,747 | $31,505,617 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AVR
ANTERIS TECHNOL...
|
Healthcare | 1.42% | 1.24% |
#12
4
Prev: #16
|
1.1 |
—
|
-644,036 | -17.0% |
P
S
|
3,145,096 | $30,979,196 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
EDIT
EDITAS MEDICINE...
|
Healthcare | 1.32% | — |
#13
Prev: #—
|
4.0 |
—
|
8,889,000 | — |
NEW
|
8,889,000 | $28,800,360 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DNLI
DENALI THERAPEU...
|
Healthcare | 1.21% | 2.12% |
#14
4
Prev: #10
|
0.5 |
—
|
-842,375 | -45.0% |
P
S
|
1,029,080 | $26,467,938 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SYRE
SPYRE THERAPEUT...
|
Healthcare | 1.15% | 1.00% |
#15
5
Prev: #20
|
1.0 |
—
|
-54,341 | -16.1% |
P
S
|
283,982 | $25,211,922 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VIR
VIR BIOTECHNOLO...
|
Healthcare | 1.15% | 1.45% |
#16
2
Prev: #14
|
1.0 |
—
|
-288,037 | -10.5% |
P
S
|
2,456,677 | $25,033,539 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 1.14% | 0.03% |
#17
186
Prev: #203
|
3.5 |
—
|
72,753 | 4850.2% |
P
S
|
74,253 | $24,859,162 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
INSM
INSMED INC
|
Healthcare | 1.12% | 0.34% |
#18
48
Prev: #66
|
3.4 |
—
|
193,128 | 545.7% |
P
S
|
228,520 | $24,364,802 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CLDX
CELLDEX THERAPE...
|
Healthcare | 1.05% | 0.80% |
#19
9
Prev: #28
|
2.9 |
—
|
191,726 | 44.8% |
P
S
|
619,542 | $23,053,158 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VKTX
VIKING THERAPEU...
|
Healthcare | 1.02% | 0.44% |
#20
36
Prev: #56
|
3.4 |
—
|
346,321 | 152.1% |
P
S
|
574,038 | $22,393,222 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TSHA
TAYSHA GENE THE...
|
Healthcare | 0.95% | 0.78% |
#21
8
Prev: #29
|
0.9 |
—
|
61,037 | 2.0% |
P
S
|
3,040,466 | $20,705,573 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MNPR
MONOPAR THERAPE...
|
Healthcare | 0.92% | 0.85% |
#22
3
Prev: #25
|
0.9 |
—
|
-46,683 | -17.7% |
P
S
|
217,595 | $20,147,121 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
OVID
OVID THERAPEUTI...
|
Healthcare | 0.91% | 0.59% |
#23
22
Prev: #45
|
3.4 |
—
|
2,873,366 | 63.2% |
P
S
|
7,417,479 | $19,953,019 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ELVN
ENLIVEN THERAPE...
|
Healthcare | 0.90% | 0.76% |
#24
9
Prev: #33
|
2.4 |
—
|
58,178 | 17.7% |
P
S
|
387,718 | $19,676,689 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ENTA
ENANTA PHARMACE...
|
Healthcare | 0.90% | 0.04% |
#25
163
Prev: #188
|
3.4 |
—
|
1,293,153 | 2518.0% |
P
S
|
1,344,510 | $19,602,956 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IWM
PUT
ISHARES TR
|
PUT Option | 0.86% | 0.40% |
#26
35
Prev: #61
|
3.3 |
—
|
35,000 | 127.3% |
P
S
|
62,500 | $18,778,125 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SPY
PUT
STATE STR SPDR ...
|
PUT Option | 0.85% | — |
#27
Prev: #—
|
3.8 |
—
|
25,000 | — |
NEW
|
25,000 | $18,669,250 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NKTR
NEKTAR THERAPEU...
|
Healthcare | 0.78% | 0.68% |
#28
12
Prev: #40
|
3.3 |
—
|
82,932 | 51.4% |
P
S
|
244,184 | $17,046,485 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
INSP
INSPIRE MED SYS...
|
Healthcare | 0.76% | 1.23% |
#29
12
Prev: #17
|
0.8 |
—
|
-30,580 | -7.5% |
P
S
|
374,617 | $16,711,664 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 0.75% | 0.77% |
#30
2
Prev: #32
|
0.3 |
—
|
-46,384 | -34.6% |
P
S
|
87,509 | $16,388,686 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ESTA
ESTABLISHMENT L...
|
Healthcare | 0.73% | 0.71% |
#31
5
Prev: #36
|
0.8 |
—
|
-27,854 | -13.0% |
P
S
|
185,619 | $15,927,966 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PRTA
PROTHENA CORP P...
|
Healthcare | 0.70% | 0.90% |
#32
10
Prev: #22
|
0.8 |
—
|
-26,908 | -1.7% |
P
S
|
1,554,535 | $15,218,898 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RYTM
RHYTHM PHARMACE...
|
Healthcare | 0.69% | 1.08% |
#33
14
Prev: #19
|
0.3 |
—
|
-75,292 | -35.6% |
P
S
|
136,158 | $15,117,623 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IKT
INHIBIKASE THER...
|
Healthcare | 0.69% | 0.65% |
#34
7
Prev: #41
|
2.3 |
—
|
780,633 | 11.8% |
P
S
|
7,387,205 | $14,996,026 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
QURE
UNIQURE NV
|
Healthcare | 0.68% | 0.07% |
#35
107
Prev: #142
|
3.3 |
—
|
248,466 | 326.0% |
P
S
|
324,672 | $14,954,392 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
RALLYBIO CORP
|
|
Unknown | 0.68% | 0.01% |
#36
229
Prev: #265
|
3.3 |
—
|
905,817 | 4411.1% |
P
S
|
926,352 | $14,821,632 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
REGN
REGENERON PHARM...
|
Healthcare | 0.63% | 0.55% |
#37
10
Prev: #47
|
3.3 |
—
|
10,054 | 82.7% |
P
S
|
22,208 | $13,847,576 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IVA
INVENTIVA SA
|
Healthcare | 0.62% | 0.71% |
#38
Prev: #38
|
3.2 |
—
|
1,432,258 | 65.9% |
P
S
|
3,606,656 | $13,633,160 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
STRO
SUTRO BIOPHARMA...
|
Healthcare | 0.61% | 0.77% |
#39
8
Prev: #31
|
0.2 |
—
|
-120,427 | -23.0% |
P
S
|
404,014 | $13,413,265 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IONS
IONIS PHARMACEU...
|
Healthcare | 0.60% | 0.71% |
#40
1
Prev: #39
|
0.7 |
—
|
5,948 | 3.7% |
P
S
|
166,286 | $13,184,817 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BBIO
BRIDGEBIO PHARM...
|
Healthcare | 0.60% | 0.41% |
#41
18
Prev: #59
|
3.2 |
—
|
82,397 | 87.4% |
P
S
|
176,689 | $13,159,797 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SRPT
SAREPTA THERAPE...
|
Healthcare | 0.60% | 0.34% |
#42
27
Prev: #69
|
3.2 |
—
|
468,591 | 178.8% |
P
S
|
730,649 | $13,129,763 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CTMX
CYTOMX THERAPEU...
|
Healthcare | 0.58% | 0.94% |
#43
22
Prev: #21
|
0.7 |
—
|
-45,072 | -1.3% |
P
S
|
3,365,118 | $12,619,193 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VOR
VOR BIOPHARMA I...
|
Healthcare | 0.57% | — |
#44
Prev: #—
|
3.7 |
—
|
680,626 | — |
NEW
|
680,626 | $12,530,325 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BIL
SPDR SERIES TRU...
|
ETF | 0.57% | 0.73% |
#45
10
Prev: #35
|
1.2 |
—
|
no change | no change |
P
S
|
135,585 | $12,425,009 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
EQ
EQUILLIUM INC
|
Healthcare | 0.55% | 0.44% |
#46
9
Prev: #55
|
0.7 |
—
|
31,910 | 0.9% |
P
S
|
3,758,569 | $12,027,421 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ANL
ADLAI NORTYE LT...
|
Healthcare | 0.54% | 0.05% |
#47
130
Prev: #177
|
3.2 |
—
|
899,896 | 763.2% |
P
S
|
1,017,805 | $11,704,758 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CLYM
CLIMB BIO INC
|
Healthcare | 0.49% | 0.24% |
#48
40
Prev: #88
|
2.7 |
—
|
224,987 | 37.6% |
P
S
|
822,649 | $10,727,343 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
XBI
PUT
SPDR SERIES TRU...
|
PUT Option | 0.49% | 0.11% |
#49
74
Prev: #123
|
3.2 |
—
|
52,400 | 349.3% |
P
S
|
67,400 | $10,666,050 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
HELIX ACQUISITI...
|
|
Unknown | 0.49% | 0.61% |
#50
6
Prev: #44
|
1.2 |
—
|
no change | no change |
P
S
|
1,000,000 | $10,600,000 | — | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-50 of 355 holdings